Adipotide
FTPP • Prohibitin-Targeting Peptide
Quick Answer
Adipotide is usually researched through fat-targeting and safety-status questions rather than broad educational queries. Readers need context on what is known, what stalled, and where evidence remains limited.
Mechanism
Experimental peptide that targets and destroys fat cells by binding to prohibitin on blood vessels supplying white adipose tissue. Causes apoptosis of fat cells.
Half-Life
Short
Administration
Technical Protocol
Adipotide: Comprehensive Research Guide
Overview
Adipotide (FTPP, Prohibitin-Targeting Peptide) is an experimental peptide designed to selectively target and destroy fat cells. It works by binding to prohibitin, a protein found on blood vessels that supply white adipose tissue, causing apoptosis (programmed cell death) of fat cells.
Mechanism of Action
Fat Cell Targeting
- Prohibitin Binding: Binds to prohibitin on fat tissue blood vessels
- Apoptosis: Causes programmed cell death of fat cells
- Selective: Targets white adipose tissue specifically
- Irreversible: Fat cell destruction is permanent
Research Status
- Experimental: Early-stage research
- Preclinical: Animal studies completed
- Human Trials: Limited human research
- Safety: Significant safety concerns identified
Research Applications
Weight Loss Research
- Fat Reduction: Significant fat loss in animal models
- Targeted: Selective fat cell destruction
- Obesity: Research into obesity treatment
- Stubborn Fat: Potential for resistant fat deposits
Safety Concerns
- Kidney Toxicity: Kidney damage reported in studies
- Side Effects: Significant side effects observed
- Research Only: Not approved for human use
- Caution: Requires careful research protocols
Dosage
- Research: 0.5-2.0 mg/kg body weight
- Frequency: Daily or every other day
- Duration: Limited duration protocols
- Monitoring: Requires medical monitoring
Side Effects
- Kidney Toxicity: Kidney damage and dysfunction
- Injection Site: Reactions at injection site
- Fatigue: Significant fatigue reported
- Dehydration: Increased risk of dehydration
Warnings
- Experimental: Research use only
- Safety: Significant safety concerns
- Medical Supervision: Requires medical supervision
- Not Approved: Not approved for human use
This information is for research and educational purposes only. Adipotide is experimental and not approved for human use.
Answer-First Research Snapshot
Evidence
Interest exists, but current user behavior suggests the page needs sharper explanation of research status, discontinued narratives, and translational uncertainty.
Dosage Context
Searchers looking for adipotide are often not just asking for dosage; they want to know whether protocol talk is even meaningful given the broader evidence and status context.
Status
This topic should be framed conservatively as research-stage and status-sensitive, with stronger emphasis on limitations than on use-case speculation.
Lead with research status before mechanism hype.
Clarify the difference between animal findings and human expectations.
Answer discontinued, safety, and evidence questions directly in the first screenful.
Peer-Reviewed Citations
Targeted apoptosis of adipocytes using adipotide
Kolonin MG, et al. • Nat Med (2012)
Access ResearchFrequently Asked Questions
What is adipotide studied for?
Adipotide is usually discussed in fat-targeting and metabolic research contexts, but readers should distinguish historical interest from robust present-day clinical relevance.
Why does adipotide need stronger status context?
Because many searches imply uncertainty about safety, discontinuation, and translational value. The page should answer those questions before giving protocol-style detail.
Is adipotide the same as an approved obesity therapy?
No. It should not be framed as equivalent to approved metabolic therapies or GLP-1 class compounds.
How should Adipotide be stored?
Store at -20°C, protect from light
Continue the Research Path
Adipotide: Research Status, Safety Questions, and Why It Still Gets Searched
Evidence-first adipotide explainer focused on research status, safety uncertainty, and translational limitations.
Peptide Regulatory Status: Approved, Prescription, or Research-Only?
Global-style regulatory explainer for peptides, including approval nuance, prescription context, and research-only labeling.
Peptide Side Effects: Class-by-Class Safety Guide
Safety-oriented guide to common side-effect patterns, evidence quality, and interpretation limits across peptide classes.
Related Metabolic Peptides
Tirzepatide
A novel dual agonist for GLP-1 and GIP receptors, used for weight management and diabetes.
metabolicSemaglutide
A widely used GLP-1 analog for type 2 diabetes and chronic weight management.
metabolicMOTS-c
A mitochondria-derived micropeptide studied for its metabolic and anti-aging effects.
metabolicAOD-9604
A GH fragment specifically designed for fat reduction and cartilage repair.